Inhibitor Therapeutics Balance Sheet (2012-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	0.10M	0.05M	0.03M	0.04M	0.02M	0.05M	11.95M	10.78M	10.10M	9.54M	8.84M	7.68M	7.10M	6.40M	5.61M	4.32M	3.70M	3.00M	2.38M	1.29M
Receivables - Other (Quarter)	-0.13M	-0.19M
Prepaid Assets (Quarter)	0.03M	0.04M	0.03M	0.02M	0.01M	0.01M	0.02M	0.05M	0.06M	0.07M	0.11M	0.11M	0.07M	0.07M	0.09M	0.10M	0.09M	0.09M	0.07M	0.08M
Current Assets (Quarter)	0.13M	0.09M	0.06M	0.06M	0.04M	0.06M	11.98M	10.84M	10.16M	9.61M	8.95M	7.79M	7.17M	6.45M	5.69M	4.42M	3.83M	3.06M	2.45M	1.38M
Non-Current Assets
Other Non-Current Assets (Quarter)	0.01M	0.00M
Non-Current Assets (Quarter)	0.01M	0.00M														0.08M	0.08M	0.07M	0.06M	0.06M
Assets (Quarter)	0.14M	0.09M	0.06M	0.06M	0.04M	0.06M	11.98M	10.84M	10.16M	9.61M	8.95M	7.79M	7.17M	6.45M	5.69M	4.51M	3.91M	3.14M	2.51M	1.43M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	0.30M	0.30M	0.28M	0.32M	0.31M	0.33M	0.15M	0.01M	0.01M	0.09M	0.03M	0.11M	0.02M	0.00M	0.02M	0.04M	0.11M	0.02M	0.05M	0.32M
Notes Payables (Quarter)			0.23M	0.28M	0.33M	0.41M	0.41M
Dividends payables (Quarter)	0.10M	0.05M	0.10M	0.15M	0.20M	0.25M
Payables (Quarter)	0.40M	0.36M	0.61M	0.75M	0.84M	0.99M	0.56M	0.01M	0.01M	0.09M	0.03M	0.11M	0.02M	0.00M	0.02M	0.04M	0.11M	0.02M	0.05M	0.32M
Accumulated Expenses (Quarter)	0.01M	0.01M	0.05M	0.02M	0.03M	0.03M	0.12M	0.07M	0.03M	0.06M	0.63M	0.04M	0.02M	0.04M	0.69M	0.03M	0.01M	0.04M	0.69M	0.03M
Other Accumulated Expenses (Quarter)	0.02M	0.03M	0.05M	0.06M	0.07M	0.07M
Short term Debt (Quarter)																0.03M	0.03M	0.03M	0.02M	0.03M
Current Deferred Revenue (Quarter)	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M
Total Current Liabilities (Quarter)	0.55M	0.59M	0.68M	0.83M	0.94M	1.09M	0.68M	0.08M	0.04M	0.16M	0.67M	0.16M	0.04M	0.04M	0.71M	0.09M	0.14M	0.09M	0.77M	0.38M
Non-Current Liabilities
Non-Current Debt (Quarter)																0.06M	0.05M	0.04M	0.04M	0.03M
Non-Current Deffered Revenue (Quarter)	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M	3.00M
Preferred Stock Liabilities (Quarter)
Non-Current Deferred Tax Liability (Quarter)							0.06M				0.06M
Total Liabilities (Quarter)	3.65M	3.63M	3.68M	3.83M	3.94M	4.09M	3.68M	3.08M	3.04M	3.16M	3.67M	3.16M	3.04M	3.04M	3.71M	3.15M	3.19M	3.13M	3.80M	3.41M
Shareholder's Equity
Total Debt (Quarter)																0.08M	0.08M	0.07M	0.06M	0.06M
Common Equity (Quarter)	-3.51M	-3.54M	-3.62M	-3.77M	-3.90M	-4.02M	8.30M	7.76M	7.11M	6.45M	5.28M	4.64M	4.14M	3.41M	1.99M	1.35M	0.72M	0.00M	-1.29M	-1.98M
Liabilities and Shareholders Equity (Quarter)	0.14M	0.09M	0.06M	0.06M	0.04M	0.06M	11.98M	10.84M	10.16M	9.61M	8.95M	7.79M	7.17M	6.45M	5.69M	4.51M	3.91M	3.14M	2.51M	1.43M
Retained Earnings (Quarter)	-57.47M	-57.59M	-57.67M	-57.82M	-57.95M	-58.07M	-45.75M	-46.29M	-46.95M	-47.61M	54.05M	54.09M	54.09M	-50.70M	-52.12M	-52.75M	54.11M	54.11M	54.11M	54.11M
Preferred Shares (Quarter)			3.96M		3.96M
Treasury Shares (Quarter)

Research Tools

Datasets

Plans

Developers

Inhibitor Therapeutics INTI Balance Sheet (2012-2026)

Research Tools

Datasets

Plans

Developers

Inhibitor Therapeutics INTI Balance Sheet (2012-2026)

Create an account

Sign In

Reset Password